Linkerbot, a Beijing-based startup specializing in highly dexterous robotic hands, is planning an initial public offering (IPO) in Hong Kong possibly within 2026 [1, 2, 3, 4]. The company has engaged China Merchants Bank International, Citic Securities, and HSBC Holdings to assist with the share sale [2, 3, 4]. Discussions about the IPO are ongoing with no final decision yet [2, 3, 4].
If completed, the listing could raise several hundred million US dollars [2, 3, 4]. Linkerbot recently completed a 1.5 billion yuan (approximately S$282 million) Series B fundraising round in February 2026, backed by investors such as DaoDe Investment, Shengshi Capital, Wise Road Capital, and Singapore’s Eastern Epic Capitals [2, 3].
Linkerbot’s flagship Linker Hand can perform delicate tasks like threading a needle as well as lifting heavy industrial loads [2, 3]. The firm claims to hold more than 80% of the global market for high-degrees-of-freedom dexterous robotic hands [2, 3]. Elon Musk has highlighted the robotic hand as one of the toughest components to develop in humanoid robots [2, 3].
China aims to accelerate humanoid robot usage, with Shanghai targeting deployment of 100,000 robots in manufacturing by 2030 [2, 3]. The Hong Kong IPO market has raised more than US$20 billion so far in 2026 with total proceeds expected to exceed US$43 billion by year-end [2, 3].
Other Chinese robotics firms, including Beijing’s Galbot and Shanghai’s AgiBot, are also planning IPOs in Hong Kong [2, 3]. Industrial robot maker Robotphoenix Intelligent Technology recently surged nearly 100% in its Hong Kong debut, with retail shares oversubscribed 14,800 times [2, 3].
Linkerbot’s plan follows its showcase of Linker Hand products at CES 2026 in Las Vegas in January [2, 3]. The company’s next step is completing IPO preparations and making a final decision on listing timing.